Cromos Pharma, where the patients are

AstraZeneca

Horizon Discovery, AstraZeneca ink agreement

Wednesday, January 8, 2014 01:26 PM

Horizon Discovery, a provider of research tools to support translational genomics research and the development of personalized medicines, and AstraZeneca have entered into a research, collaboration and license agreement to explore oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets.

More... »

CRF Health eCOA webinar series

MedImmune, Immunocore enter immunotherapy agreement

Wednesday, January 8, 2014 01:21 PM

MedImmune, AstraZeneca’s global biologics R&D arm, has entered into an oncology research collaboration and licensing agreement with Immunocore, a privately-held, U.K.-based biotechnology company. Both companies will research and develop novel cancer therapies using Immunocore’s Immune Mobilizing Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology.

More... »


Cancer Research U.K., AstraZeneca sign deal

Friday, January 3, 2014 02:46 PM

Cancer Research U.K. and Cancer Research Technology, the charity's development and commercialization arm, have reached an agreement with AstraZeneca to take AZD2098, an experimental drug originally designed for asthma, into a clinical trial to treat kidney cancer.

More... »

Molecular Profiles joins consortium to drive pediatric formulation development

Thursday, January 2, 2014 10:30 AM

A collaborative pharmaceutical project focused on improving the pathway for developing pediatric formulations has been given the go-ahead after successfully securing an innovation grant.

More... »

AstraZeneca to acquire Bristol-Myers Squibb share of diabetes alliance assets

Friday, December 20, 2013 11:00 AM

AstraZeneca will acquire the entirety of Bristol-Myers Squibb's interest in the companies' diabetes alliance for $2.7 billion, and up to $1.4 billion in regulatory, launch and sales-related payments. AstraZeneca also has agreed to pay various sales-related royalty payments up until 2025 and may make payments up to $225 million when certain assets are subsequently transferred.

More... »

AstraZeneca donates Brixham Environmental Laboratory to Plymouth University

Monday, December 9, 2013 12:25 PM

AstraZeneca will donate its Environmental Laboratory in Brixham to Plymouth University to ensure the lab continues to serve scientific and research purposes.

More... »

Taigle, SAFE-BioPharma partner

Friday, December 6, 2013 01:00 PM

Taigle, an Irvine, Calif.-based technology company, has partnered with the SAFE-BioPharma Association, which manages the global SAFE-BioPharma digital identity and signature standard. 

More... »

PharmaTimes recognizes top U.S. clinical researchers

Tuesday, November 19, 2013 01:00 PM

Winners of the U.S. Clinical Researcher of the Year competition were announced following an intense finals day hosted by partner SAS at its global headquarters in Cary, N.C.

More... »

U.S. Clinical Researchers of the Year announced

Tuesday, November 12, 2013 08:00 AM

The 2013 U.S. Clinical Researchers of the Year winners have been revealed at the Umstead Hotel in North Carolina, U.S.

More... »

AstraZeneca proposes closing Brixham Environmental Laboratory

Friday, October 25, 2013 11:45 AM

AstraZeneca has announced proposals to close its Environmental Laboratory in Brixham, Devon, U.K. The laboratory, with 71 staff members, provides specialist services to assess the impact of pharmaceuticals and chemicals used by a range of industries on the environment.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 21

Healthcare IPOs soar in first quarter

Survey compares 'push/pull' tactics in patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs